Affordable Access

Publisher Website

Invited papers

British Journal of Cancer
Nature Publishing Group
Publication Date
DOI: 10.1054/bjoc.2001.1916
  • British Cancer Research Meeting 2001
  • Agricultural Science
  • Medicine


CT1 CONTINUOUS VS INTERMITTENT CHEMOTHERAPY FORADVANCED COLORECTAL CANCER, PRELIMINARY RESULTS OF THE MRC CR06B RANDOMISED TRIAL T Maughan on behalf of the MRC Colorectal Cancer Group and all the participants Cancer Division, MRC Clinical Trials Unit, 222 Euston Road, London, UK A survey of UK clinicians suggested that there was no consistent policy regarding the duration of treatment for patients receiving chemotherapy for advanced colorectal cancer. Patients who were responding or had stable disease after receiving 12 weeks of de Gramont, Lokich or Raltitrexed therapy were therefore randomised to either ‘continue’ therapy until progression, or ‘stop’, re-starting on the same therapy on progression. The trial was closed at the end of August 2000, when 354 patients had been entered from 42 UK centres in 4 years. CT2 IV VS IHA 5FU/LEUCOVORIN FOR COLORECTAL LIVERMETASTASES: PRELIMINARY RESULTS OF THE MRC CT3 PRELIMINARY RESULTS OF A MRC RANDOMISEDCONTROLLED TRIAL OF POST-OPERATIVE IRRIGATION OF SUPERFICIAL BLADDER CANCER P Whelan, G Griffiths, M Stower, D Wallace, J Hetherington, T Hargreave, P English, P Weston & M Parmar on behalf of the MRC Bladder Cancer Group. MRC Clinical Trials Unit, 222 Euston Road, London, UK A multi-centre, randomised controlled trial comparing post-operative irrigation with CT4 PRELIMINARY EVIDENCE THAT AN ORAL BISPHOSPHONATECAN DELAY SYMPTOMATIC PROGRESSION OF BONE METASTASES FROM PROSTATE CANCER: FIRST RESULTS OF THE MRC PR05 TRIAL DP Dearnaley1, MP Sydes2 on behalf of the MRC PR05 collaborators, 1The Institute of Cancer Research and Royal Marsden NHS Trust, Downs Rd, Sutton, Surrey, SM2 5PT, 2MRC Clinical Trials Unit, 222 Euston Rd, London, NW1 2DA, UK British Journal of Cancer (2001) 85(Suppl 1), 1–11 © 2001 Cancer Research Campaign doi: 10.1054/ bjoc.2001.1916, available online at on no irrigation was conducted in the UK (MRC BS04 trial). Eligible patients had newly diagnosed Ta or T1 transitional cell carcinoma

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times